Skip to main content
. 2022 Jan 18;98(3):e302–e314. doi: 10.1212/WNL.0000000000013055

Figure 4. Relative Frequencies of Low-Frequency Safety Endpoints by Treatment Group and Presence of CMBs.

Figure 4

CAA = cerebral amyloid angiopathy; CMB = cerebral microbleed; PH2 = parenchymal hematoma type 2.